abstract |
The present invention relates to methods of treating PCAF-mediated conditions using compounds of formula (I) or a pharmaceutically acceptable salt thereof, wherein ring R 1 、R 3 ‑R 6 X and each R e Having any of the values defined in the specification. The invention also includes novel compounds of formula (I) and salts thereof, and pharmaceutical compositions comprising compounds of formula (I) or pharmaceutically acceptable salts thereof. |